Moderate

Intraoperative cell salvage

Patient blood management · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Collection, washing and reinfusion of the patient's own shed blood during surgery to reduce allogeneic transfusion. Used in major blood-loss surgery and for patients declining donor blood; requires attention to specific contraindications and complications.

Red flags

  • Gross contamination with bowel content, pus or antiseptic in the surgical field
  • Hypotension or wheeze during reinfusion (salvaged blood reinfusion syndrome)
  • Ongoing bleeding with dilutional coagulopathy despite red-cell return
  • Air in the reinfusion line

Assessment

Differential diagnosis

  • Appropriate candidate — anticipated loss >500-1000 mL or rare antibodies/declined donor blood
  • Relative contraindication — contamination with bowel content, infection or malignant cells in field
  • Obstetric salvage requiring leucocyte depletion filter
  • Need for allogeneic transfusion despite salvage (dilutional coagulopathy)

Investigations

  • Baseline and serial haemoglobin/haematocrit and coagulation screen
  • Group and save/crossmatch maintained despite salvage
  • Assessment of surgical field for contamination (bowel, infection, amniotic fluid, tumour)
  • Platelets and fibrinogen monitoring in large-volume salvage (washed cells lack clotting factors/platelets)

Management

  • Identify suitable cases pre-operatively and set up the cell-salvage device with trained operator
  • Collect shed blood with appropriate anticoagulant (heparinised or citrate saline) into the reservoir
  • Wash and concentrate red cells to produce packed autologous cells for reinfusion
  • Use a leucodepletion filter where malignancy or amniotic fluid contamination is a concern (per guidance)
  • Reinfuse through a standard blood giving set; label the reinfusion bag clearly with patient details
  • Monitor for salvaged-blood reinfusion reactions, hypotension and air embolism during return
  • Replace coagulation factors and platelets separately in large-volume salvage (washed cells provide red cells only)
  • Document volume collected and reinfused in the transfusion record

Drugs & doses

Reservoir anticoagulant — Heparinised saline 30,000 units heparin in 1 L 0.9% saline (run per device protocol)
Alternative anticoagulant — Citrate (ACD-A) per device protocol
Replace clotting factors if diluted — Tranexamic acid 1 g IV and fibrinogen/FFP as guided by coagulation results

Disposition

Routine recovery with transfusion documentation; ongoing coagulopathy or large losses may require critical-care admission and further component therapy.

Complications & pitfalls

  • Salvaged-blood reinfusion reaction (hypotension, 'salvaged blood syndrome')
  • Dilutional coagulopathy and thrombocytopenia
  • Air embolism during reinfusion
  • Infection/tumour cell reinfusion (mitigated by leucodepletion filters)
  • Haemolysis from inadequate washing

Exam pearls

  • Washed cells contain red cells only — give platelets, FFP and fibrinogen separately in large-volume salvage
  • Cell salvage is an acceptable technique for many patients who decline allogeneic blood, including some Jehovah's Witnesses — discuss specifics in advance
  • Leucodepletion filters allow use in obstetric and oncological surgery where previously contraindicated
  • Never reinfuse under pressure from the same line that could entrain air
  • Cell salvage complements, but does not replace, a crossmatch for major-haemorrhage contingency

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.